{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:48:44Z","timestamp":1761515324890,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.4158\/ep.11.3.194","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:32:26Z","timestamp":1365197546000},"page":"194-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Systemic Effects of Fluticasone Nasal Spray: Report of 2 Cases"],"prefix":"10.1016","volume":"11","author":[{"given":"Angelo A.","family":"Licata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.11.3.194_bb0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0889-8529(05)70017-7","article-title":"The science and therapy of glucocorticoid-induced bone loss","volume":"27","author":"Lane","year":"1998","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.4158\/EP.11.3.194_bb0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4065\/79.4.458","article-title":"Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial","volume":"79","author":"Kemp","year":"2004","journal-title":"Mayo Clin Proc."},{"key":"10.4158\/EP.11.3.194_bb0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4158\/EP.6.4.311","article-title":"Effect of inhaled glucocorticoid, flunisolide, on bone mineral density: a 2-year prospective, controlled trial","volume":"6","author":"Kaye","year":"2000","journal-title":"Endocr Pract."},{"key":"10.4158\/EP.11.3.194_bb0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1378\/chest.124.1.57","article-title":"Lack of long-term adverse adrenal effects from inhaled triamcinolone: Lung Health Study II","volume":"124","author":"Eichenhorn","year":"2003","journal-title":"Chest."},{"key":"10.4158\/EP.11.3.194_bb0025","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1651-2227.2000.tb00728.x","article-title":"Systemic activity versus systemic adverse effects of nasal glucocorticoids in the treatment of allergic rhinitis","volume":"89","author":"Wolthers","year":"2000","journal-title":"Acta Paediatr."},{"key":"10.4158\/EP.11.3.194_bb0030","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.11.3.194_bb0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0954-6111(06)80268-4","article-title":"Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids","volume":"85","author":"Brown","year":"1990","journal-title":"Respir Med."},{"key":"10.4158\/EP.11.3.194_bb0040","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1097\/01.CCM.0000063447.37342.A9","article-title":"Glucocorticoid insufficiency in patients who present to the hospital with severe sepsis: a prospective clinical trial","volume":"31","author":"Manglik","year":"2003","journal-title":"Crit Care Med."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20398918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20398918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/N5P06UFA6UBYY0GF.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:45:21Z","timestamp":1761515121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20398918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S1530891X20398918"],"URL":"https:\/\/doi.org\/10.4158\/ep.11.3.194","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Effects of Fluticasone Nasal Spray: Report of 2 Cases","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.11.3.194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}